Guardian Pharmacy Services (NYSE:GRDN) Shares Gap Up on Insider Buying Activity

Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) gapped up before the market opened on Thursday after an insider bought additional shares in the company. The stock had previously closed at $21.27, but opened at $22.04. Guardian Pharmacy Services shares last traded at $22.02, with a volume of 4,580 shares trading hands.

Specifically, Director Steven D. Cosler acquired 7,000 shares of Guardian Pharmacy Services stock in a transaction on Tuesday, November 19th. The shares were purchased at an average price of $21.22 per share, with a total value of $148,540.00. Following the acquisition, the director now owns 17,713 shares in the company, valued at $375,869.86. This represents a 65.34 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Analysts Set New Price Targets

GRDN has been the subject of a number of recent research reports. Truist Financial boosted their target price on Guardian Pharmacy Services from $22.00 to $24.00 and gave the stock a “buy” rating in a research report on Friday, November 15th. Stephens assumed coverage on shares of Guardian Pharmacy Services in a research report on Tuesday, October 22nd. They set an “overweight” rating and a $21.00 target price on the stock. Finally, Raymond James assumed coverage on shares of Guardian Pharmacy Services in a research report on Monday, October 21st. They set an “outperform” rating and a $21.00 price target for the company.

Guardian Pharmacy Services Price Performance

Guardian Pharmacy Services (NYSE:GRDN) last announced its quarterly earnings results on Tuesday, November 12th. The company reported ($2.00) EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($2.19). The firm had revenue of $314.39 million during the quarter, compared to the consensus estimate of $303.21 million. On average, sell-side analysts forecast that Guardian Pharmacy Services, Inc. will post 0.86 EPS for the current fiscal year.

Hedge Funds Weigh In On Guardian Pharmacy Services

A number of hedge funds and other institutional investors have recently made changes to their positions in GRDN. Seven Grand Managers LLC bought a new position in Guardian Pharmacy Services during the third quarter worth about $2,515,000. Allspring Global Investments Holdings LLC acquired a new stake in shares of Guardian Pharmacy Services during the third quarter worth about $5,460,000. Stephens Inc. AR acquired a new stake in shares of Guardian Pharmacy Services during the third quarter worth about $189,000. Royce & Associates LP bought a new position in shares of Guardian Pharmacy Services during the 3rd quarter valued at about $1,260,000. Finally, Foundry Partners LLC acquired a new position in shares of Guardian Pharmacy Services in the 3rd quarter valued at approximately $1,680,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.